Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transformative Healthcare Summit in Palm Beach All Posts The Sen-Jam Perspective Investor Corner Press &
The End of Sickcare: From the Inside Out: A Spotlight on Cellular Longevity at the Global Passion Project Summit All Posts The Sen-Jam Perspective Investor
Behind the Breakthrough: Strategic Insights from Sen-Jam’s Executive Leadership and Destum Partners All Posts The Sen-Jam Perspective Investor Corner Press & Media Coverage Pipeline &
Sen-Jam Pharmaceutical Answers Surgeon General’s Alarm with a New Therapeutic Aimed at Tackling Alcohol Related Risks All Posts The Sen-Jam Perspective Investor Corner Press &
Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech All Posts The Sen-Jam Perspective Investor Corner
Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C All Posts The Sen-Jam Perspective Investor Corner Press & Media Coverage Pipeline & Product Deep
Sen-Jam Pharmaceutical Announces Ethics Approval in Australia for SJP-001 Clinical Trial Targeting Inflammation and Metabolic Health All Posts The Sen-Jam Perspective Investor Corner Press &
Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ashley St. John to its Scientific Advisory Board All Posts The Sen-Jam Perspective Investor Corner Press
Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships for SJP-001 & SJP-002C All Posts The Sen-Jam Perspective Investor Corner Press & Media Coverage Pipeline
Sen-Jam Pharmaceutical Announces Preliminary Results from Phase 2 Clinical Trials of SJP-002C for Upper Respiratory Infections/COVID-19 All Posts The Sen-Jam Perspective Investor Corner Press &